Although activation of the PR in the presence of an estrogen-activated ER complex has been associated with a more favorable outcome (28, 31), one cannot ignore the fact that the PR/ER complex is recruited to the PR-regulated MYC oncogene, and that PR-regulated genes have previously been linked to increased tumor progression (19). The gene discussed is ESR1; the disease is neoplasm.